| Similar Articles |
|---|
 |
CFO
December 1, 2004
Kate O'Sullivan |
What Will Judy Do? Merck's CFO may be fighting simply to keep her current job rather than contending for the CEO seat... CFO to the Rescue... CFOs on the Move...   |
The Motley Fool
July 23, 2004 |
The Mysterious CFO You'll hear about many CFOs as you read financial articles, but what exactly do CFOs do besides make occasional brief appearances? |
CFO
March 1, 2008
Kate O'Sullivan |
As the World Churns Some of Corporate America's biggest names parted ways with their CFOs in the past year. |
BusinessWeek
September 20, 2004
Amy Barrett |
Merck: Who Will Revive The Giant? Earnings and new-drug disappointments have investors worried about succession. |
CFO
January 1, 2006
Lori Calabro |
International Rectifier's Mike McGee Here's an interview with McGee who, as the first non-Japanese chairman of a Japanese-listed company, had to orchestrate a restructuring that ran contrary to traditional Japanese business practices. |
The Motley Fool
March 15, 2011
Cindy Johnson |
Dell Board Member Resigns: What Does She Know That You Don't? The positive read on the resignation is ... umm, don't see one. |
CFO
Kris Frieswick |
Clinical Trials A new kind of pricing pressure puts pharmaceutical CFOs in an unfamiliar role: evangelist... |
CFO
July 15, 2008
Kate Plourd |
Eight Isn't Enough BearingPoint, the consultancy that used to be part of KPMG, burns through its eighth CFO in nine years. The latest to go lasted just three weeks. |
CFO
September 1, 2005
Don Durfee |
The 411 on 404 Reporting a material weakness in controls can cost shareholders millions and some CFOs their jobs. |
The Motley Fool
January 11, 2006
Selena Maranjian |
What Does a CFO Do? Investors, this executive determines what a company's financial needs are and will be, how best to finance those needs, and informs all stakeholders (investors, creditors, analysts, employees, management) of the firm's financial condition. |
The Motley Fool
December 21, 2006
Brian Lawler |
Dueling Fools: Merck Bull Rebuttal Plenty of cash. Big pipeline. Not to worry. The future can't be predicted, but Merck's history shows its ability to weather even the toughest pharmaceutical-development environments. |
CFO
March 1, 2008
Kate Plourd |
Closing Remarks Retiring Cisco CFO Dennis Powell leaves with this message: the key to finance is people and strategies, not just a good accounting system. |
CFO
August 1, 2002
Joseph McCafferty |
Interim CFOs In general, companies are taking longer to fill the CFO position -- usually six months to a year. But since the job is too crucial to leave open that long, companies like Aetna, New York Life, Sapient, and Citrix Systems have, for varying amounts of time, gone the interim CFO route. |
The Motley Fool
June 3, 2010
Brian Orelli |
When All Else Fails, Sue Your Competitors Biogen thinks its patent covers its competitors' drugs in addition to Avonex and has filed a lawsuit demanding royalties from its competitors. |
CFO
April 1, 2007
Laura DeMars |
The Tenure Track Amid rapid turnover in the ranks of chief financial officers, this trio of CFOs stayed in their posts longer than expected... Initially set up in 1999 to provide wealth-management services for multimillionaires, will MyCFO pass the smell test?... |
| Knowledge@Wharton |
The Changing Role of the CFO Companies are once again demanding hardcore accounting, financial reporting and risk-management skills. This represents a shift back to the roots of the CFO position... |
The Motley Fool
October 23, 2006
Brian Lawler |
Merck Mints Money The pharmaceutical hangs on, despite ongoing Vioxx woes. Conservative investors may do best to stay away from Merck until a lower share-price opportunity presents itself, now that shares are no longer sporting such a large Vioxx discount. |
CFO
August 1, 2003
Alix Nyberg |
Roads Less Traveled: Nontraditional CFOs In a time of increased regulation, can CFO candidates with no previous finance-department experience be successful? |
CFO
May 1, 2005
Kris Frieswick |
What Does Your CEO Really Know? How much do chief executives know about company finances? We asked more than 300 CFOs to rate their boss's finance IQ. |
The Motley Fool
January 31, 2005
Stephen D. Simpson |
Merck Takes Another Body Blow Loss of exclusivity on major osteoporosis drug could take steam out of the recovery process. Investors in Merck just can't catch a break. |
CFO
January 1, 2006
Kate O'Sullivan |
CFO Confidential At many companies the CFO is a trusted confidant of the CEO, a valuable sounding board for all kinds of issues. But when CFOs themselves need advice, whom do they call? |
CFO
June 1, 2006
Alix Nyberg Stuart |
What Women Want In finance, the operative words are opportunity, flexibility, and balance. As they approach the top position -- CFO, the pull between work and life seems to tug harder at women than at men. |
CFO
November 1, 2008
Alix Stuart |
Making the Leap There are many ways to get to the top spot in finance. |
The Motley Fool
September 27, 2006
Selena Maranjian |
Musical Chairs With CFOs Investors, changes in CFOs are worth investigating. |
CFO
March 1, 2005
Roy Harris |
Are You Ready for Your Close-up? As the CFO has increasingly had to meet the press, there have been rough adjustments for both sides. |
Entrepreneur
September 2002
C.J. Prince |
Woe is the CFO These days, CFO may have more responsibility than the acronym was meant to handle. Does yours have what it takes to handle the scrutiny and the pressure? |
CFO
June 1, 2007
Julia Homer |
The Diversity Gap Most finance departments are conspicuously white. Changing that is not a priority for most CFOs. |
CFO
May 1, 2007
Alix Nyberg Stuart |
Board Battles Even as conflicts between CEOs and directors erupt, finance chiefs can wield influence on both sides. |
CFO
February 1, 2009
Scott Leibs |
Moving On, Happily Most CFOs leave their jobs in triumph, not disgrace, a new KPMG study shows. |
The Motley Fool
May 29, 2009
Brian Orelli |
Merck's Bad News Nothing to Sneeze At The U.S. Patent and Trademark Office reexamination of Merck's patent on allergy medication, Singulair, is nothing to sneeze at. The $2.8 billion worth of Singulair that Merck sold in the U.S. last year made up 12% of its total pharmaceutical sales. |
CFO
June 1, 2008
Alix Stuart |
Secrets of Their Success How the top women in finance staked their claims to the C-suite. |
CFO
March 1, 2005
Julia Homer |
Time and Change Today's CFOs no longer labor in obscurity, but the notoriety of the few has increased the pressure on the rest. |
CFO
November 1, 2003
David M. Katz |
The Price They're Paid Even without stock options, top finance chiefs are changing in hefty pay packages. |
The Motley Fool
July 21, 2010
Brian Orelli |
Biogen Looks Good Now, but What About Tomorrow? Biogen Idec saw revenue increase 11% and adjusted earnings per share jump almost 75%, which is all well and good, but the longer-term prospects for the company aren't nearly as impressive. |
CFO
December 1, 2008
Kate O'Sullivan |
Cold Cuts CFOs plan to pare payrolls by any and all means available to them. |
CFO
April 1, 2004
Julia Homer |
On Trial Sometimes, when operations can't deliver an expected result, the CFO is asked to help produce that result like a relief pitcher called in to pull his team out of a jam. All too often, that has involved financial manipulation. |
The Motley Fool
January 31, 2007
Brian Lawler |
Merck Plays the Waiting Game New acquisitions may help the drugmaker weather tough times. Investors, take note. |
CFO
December 1, 2003
Kate O'Sullivan |
Embracing Change There is an upside to the high CFO turnover rate these days: lots more opportunities for those looking to make a move. |
CFO
June 1, 2004
Kate O'Sullivan |
CPA Ascendant With accounting savvy more important than ever, is the CPA (rather than the MBA) the new must-have credential for finance execs? |
CFO
November 1, 2004
Kate O'Sullivan |
Trading Places Why did Citigroup CFO Todd Thomson switch jobs with Sallie Krawcheck?... Kevin Parker lands in the hot seat at PeopleSoft... CFOs on the move... |
The Motley Fool
January 26, 2006
Rich Duprey |
Will Acquisitions Patch Merck's Pipeline? The pharmaceutical giant announces a biotech shopping spree. A few key acquisitions that contribute late-stage drugs and significant revenue might be all Merck needs to keep its pipeline open. Investors, take note. |
The Motley Fool
February 10, 2010
Brian Orelli |
Icahn's Smiling -- Should We Be? Biogen Idec's fourth quarter results must have made Carl Icahn smile. But the guidance for next year gives pause. |
The Motley Fool
January 25, 2005
Stephen D. Simpson |
Prognosis Good for Merck The pharmaceutical weathered a tough year but should ride out its Vioxx troubles. While strict value investors may be put off, risk-tolerant investors can buy these shares today. |
CFO
March 1, 2005
Kate O'Sullivan |
Where Are They Now? A look at what some of the most significant CFOs from the past two decades are doing today. |
CFO
August 1, 2004
Kate O'Sullivan |
Switching Industries A new survey reports that 75 percent of all finance executives looking for new jobs are seeking new sectors. |
CFO
October 1, 2003 |
Letters to the Editor CFOs should quit whining... can nontraditional CFOs succeed?... disagreement over the options debate. |
CFO
May 8, 2006
Scott Leibs |
Fresh Start A break from CFO duties can be rejuvenating, but executive recruiters warn that too much time out of the workforce can hurt your options if you want to get back into finance. |
CFO
June 1, 2003
Roy Harris |
JV On The Rocks Without plenty of attention and TLC, a joint venture may well run aground. |
CFO
April 1, 2006
Kate O'Sullivan |
Calming the Waters What happens when the CEO and CFO just don't get along? And what should CFOs do when they find themselves locking horns with their boss? |
The Motley Fool
January 31, 2007
Brian Lawler |
FDA Says Hurray for More Drug Safety The FDA outlines its proposal to increase drug safety. Whatever the FDA does, pharmaceutical investors should hope that its renewed interest in drug safety doesn't make the already lengthy process of bringing drugs to market any longer. |
